← Leaderboards
Mark L McLaughlin
Louisiana State Univ A&M Col Baton Rouge
$1,799,723
Attributed
$2,325,436
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $375K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,325,436 · 8
By mechanism
R21$779,252 · 2
R01$701,364 · 2
R41$469,801 · 2
R43$375,019 · 2
Top collaborators
- Lori A Hazlehurst3 shared
- Priyesh Jain1 shared
- David L Morse1 shared
- Rajesh R Nair1 shared
- Shari Pilon-Thomas1 shared
Most similar at Louisiana State Univ A&M Col Baton Rouge
Same institution · by research overlap
- Thomas R. Klei$8,495,922
Others in their field
Top investigators on “Binding (Molecular Function)”
- David Heimbrook · Leidos Biomedical Research, Inc.$99,890,135
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Dennis R. Burton · Scripps Research Institute$64,421,085
- Michael P Snyder · Yale University$62,252,853
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$48,139,978
- Barton F Haynes · Duke University$39,418,096
Research focus
Binding (Molecular Function)TumorIn VitroConformationCell LineSynthetic PeptideDipeptidesCellsDrug Design /Synthesis /ProductionSurfacePharmaceutical PreparationsAffinityRecombinantsScaffoldMultiple MyelomaIn VivoNecrosisDrug CandidateImmuneDrug Screening /EvaluationCd44 GeneMeasurementHome EnvironmentPeptides
Grant awards (12)
Targeting CD137L to MC1R-Expressing Melanoma Cells and Tumors.$244,801
R41 · FY2015 · CA · contact PI
Second generation MTI-101 analogs using a novel peptoid-peptide hybrid beta-hairp$225,000
R41 · FY2014 · CA · contact PI
Targeting CD44 in the bone marrow microenvironment of MM$218,817
R43 · FY2012 · CA
Chemical Optimization Designed to Increase the in vivo Efficacy of HM-27 for the$156,202
R43 · FY2012 · CA
A Molecular Clamp that Inhibits CRF Amidation$155,752
R21 · FY2006 · GM · contact PI
A Molecular Clamp that Inhibits CRF Amidation$188,500
R21 · FY2005 · GM
HIV-1 Protease Inhibitors with Extended Conformations$217,500
R21 · FY2004 · AI
HIV-1 Protease Inhibitors with Extended Conformations$217,500
R21 · FY2003 · AI
BETA-SHEET MIMICS FROM CONSTRAINED DIPEPTIDE UNITS$182,340
R01 · FY2001 · AG
PEPTIDES ACTIVE AGAINST INTRACELLULAR PATHOGENIC DISEASE$171,443
R01 · FY2001 · GM
BETA-SHEET MIMICS FROM CONSTRAINED DIPEPTIDE UNITS$180,930
R01 · FY2000 · AG
PEPTIDES ACTIVE AGAINST INTRACELLULAR PATHOGENIC DISEASE$166,651
R01 · FY2000 · GM